CKD cases surge to 16.38% in Indians aged 15+

Experts urge early detection & better access to care

Strides Pharma global to acquire 100% stake in Amextel

Amexel aims to generate revenue through facilitation services and a profit-sharing model linked to the commercialization of products

Sigachi Industries signs MoU with INS Kalinga to promote healthy living

The programme will take place on the 2nd Sunday of every month

Glenmark Pharma launches Empagliflozin and its fixed-drug combinations in India

Empagliflozin and its Fixed Drug Combinations (FDCs) have been launched under the brand names Glempa, Glempa –L and Glempa-M

Alkem launches generic empagliflozin and its combinations in India under ‘Empanorm’

Empagliflozin is used in the treatment of type-2 diabetes mellitus, chronic kidney disease and heart failure

UFlex secures USFDA approval for recycled PE in food packaging

Announces Rs. 317 crore investment in new recycling plant

Zota Health Care launched B2C online portal ‘davaindia’

This e-commerce platform is launched as a hyperlocal model

Syngene acquires first US biologics facility for $36.5 million

Overall investment in the US facility is estimated around US$50 million

Indoco’s clinical research organisation ‘AnaCipher’ completes USFDA inspection

Emcure partners with Vidya Balan for Arth supplements,

Vidya will spark conversations around less discussed and important aspects of health, including intimate care and sleep issues